Maurizio Fava

Affiliations: 
MGH Depression Clinical and Research Program 
Area:
Psychiatry
Google:
"Maurizio Fava"
Mean distance: 106866
 
Cross-listing: PsychTree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lamon-Fava S, So J, Mischoulon D, et al. (2020) Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 164: 102219
Choi KW, Jang EH, Kim AY, et al. (2020) Predictive inflammatory biomarkers for change in suicidal ideation in major depressive disorder and panic disorder: A 12-week follow-up study. Journal of Psychiatric Research. 133: 73-81
Park ER, Sylvia LG, Streck JM, et al. (2020) Launching a resiliency group program to assist frontline clinicians in meeting the challenges of the COVID-19 pandemic: Results of a hospital-based systems trial. General Hospital Psychiatry
Fava M, Mazzone E, Freeman M, et al. (2020) Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 32: e16-e24
Jha MK, Fava M, Minhajuddin A, et al. (2020) Association of anger attacks with suicidal ideation in adults with major depressive disorder: Findings from the EMBARC study. Depression and Anxiety
Sakurai H, Jain F, Foster S, et al. (2020) Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review. Journal of Affective Disorders. 276: 660-666
Shelton RC, Fava M, Freeman MP, et al. (2020) Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: Analysis of the CLARITY study. Journal of Affective Disorders. 277: 478-485
Papakostas GI, Fava M, Freeman MP, et al. (2020) Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study. International Clinical Psychopharmacology
Johe KK, Kay G, Kumar S, et al. (2020) NSI-189 phosphate, a novel neurogenic compound, selectively benefits moderately depressed patients: A post-hoc analysis of a phase 2 study of major depressive disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 32: 182-196
Dichtel LE, Carpenter LL, Nyer M, et al. (2020) Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study. The American Journal of Psychiatry. appiajp202019080844
See more...